Ind-Swift Laboratories vs Peers
- Market cap
- ₹3,073 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹254.77 – ₹477.70
Ind-Swift Laboratories ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Ind-Swift Laboratories. Its P/E of 22.5 compares with a peer median of 22.5.
Ind-Swift Laboratories vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Ind-Swift Laboratories | 353.85 | -3.35% | 3,073 | 22.5 | 2.85 | 14.5% | +18.5% |
| Ind-Swift Laboratories | 353.85 | -3.35% | 3,073 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Ind-Swift Laboratories peer comparison — frequently asked questions
Who are Ind-Swift Laboratories' competitors?
Ind-Swift Laboratories' listed peers in Drug Manufacturers - Specialty & Generic include Ind-Swift Laboratories, ranked here by market capitalisation.
How does Ind-Swift Laboratories' P/E compare with its peers?
Ind-Swift Laboratories trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Ind-Swift Laboratories' peers?
By market capitalisation, the largest company in the group is Ind-Swift Laboratories at ₹3,073 crore, against ₹3,073 crore for Ind-Swift Laboratories.
Same Data For Peers
Trade Ind-Swift Laboratories With ATS
Track INDSWFTLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.